The Technical Analyst
VanEck Vectors Biotech [BBH]
Exchange: NASDAQ
VanEck Vectors Biotech Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.11% $157.33
America/New_York / 24 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 461.04 mill |
| EPS: | 9.88 |
| P/E: | 15.93 |
| Earnings Date: | N/A |
| SharesOutstanding: | 2.93 mill |
| Avg Daily Volume: | 0.0072 mill |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.08x |
| Company: PE 15.93 | sector: PE 14.70 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.92x |
| Company: PE 15.93 | industry: PE 17.27 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 155.49 - 159.17 ( +/- 1.17%) |
| ATR Model: 14 days |
Forecast:
16:00 - $157.60
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $157.60
Forecast 2: 16:00 - $157.60
Forecast 3: 16:00 - $157.60
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $157.33 (0.11% ) |
| Volume | 0.0061 mill |
| Avg. Vol. | 0.0072 mill |
| % of Avg. Vol | 84.90 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BBH
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
BBH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Last 10 Buy Signals
Latest Press Releases
2023-12-15 19:57:00 - Press Release
Vaneck Announces Year-end Distributions For Vaneck Equity Etfs
New york--(business wire)--vaneck announced today the 2023 annual distributions per share for its vaneck® equity exchange-traded funds.
Latest News
2024-04-15 07:20:37 - Zacks Investment Research
Should You Invest in the VanEck Biotech ETF (BBH)?
The VanEck Biotech ETF (BBH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
2024-03-09 03:59:00 - Seeking Alpha
Why Biotech Stocks May Be Ready For A Recovery
Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a healthy recovery.
2024-02-14 17:51:14 - Zacks Investment Research
Where Are Biotech ETFs Headed After Q4 Earnings?
2024-02-12 07:21:12 - Zacks Investment Research
Should You Invest in the VanEck Biotech ETF (BBH)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011.
2024-01-09 12:47:21 - Zacks Investment Research
Biotech ETFs Stage Solid Comeback at the Start of 2024
The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-time.
2024-01-03 10:07:01 - ETF Trends
AI Advancements Could Be Boon for Biotech Industry
Generative artificial intelligence was a point of emphasis for investors in 2023. That movement is just getting started.
2023-12-09 11:08:29 - Seeking Alpha
BBH: A Solid Way To Play A Comeback In Biotech
Biotech sector has potential for outperformance in the next year. VanEck Biotech ETF is a good product to consider for exposure to the sector. BBH focuses on large-cap biotech stocks, offering a more balanced choice with better risk-adjusted returns.
2023-10-11 07:32:13 - Zacks Investment Research
Should You Invest in the VanEck Biotech ETF (BBH)?
The VanEck Biotech ETF (BBH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
2023-09-13 03:08:35 - Seeking Alpha
BBH: Our Favorite Biotech ETF Can Keep Outperforming
VanEck Biotech ETF has outperformed alternative industry ETFs in recent years through its concentration in large-cap leaders. Biotech companies are benefiting from new artificial intelligence tools set to streamline and accelerate R&D programs. We are bullish on biotech stocks, which benefit from significant long-term growth opportunities.
2023-09-12 15:05:10 - Zacks Investment Research
Time for Gilead Sciences-Heavy ETFs?
